Akèy › Metiyè › Chemists › Lexington, MA
Chemists nan Lexington, MA: Salè H-1B
35 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Lexington, MA. Salè baz medyàn ofri $129,400; mwatye mitan $109,199–$153,000.
Demann (LCA)35
Salè medyan ofri$129,400
Mwatye salè yo$109,199–$153,000
10yèm–90yèm pousantaj$89,078–$167,000
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $85,000 |
| Nivo II (kalifye) | $100,308 |
| Nivo III (eksperyans) | $126,540 |
| Nivo IV (plen kompetans) | $159,934 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Wave Life Sciences USA, Inc. | 12 | $152,337 |
| Takeda Development Center Americas, Inc. | 5 | $152,834 |
| Dicerna Pharmaceuticals, Inc. | 3 | $130,410 |
| Henkel Corporation | 2 | $95,742 |
| United Pharma Technologies, Inc. | 2 | $114,400 |
| Novo Nordisk Research & Development US, Inc. | 2 | $98,800 |
| Pulmatrix, Inc. | 1 | $112,000 |
| Shire Human Genetic Therapies Inc. | 1 | $78,814 |
| Novo Nordisk, Inc. | 1 | $150,000 |
| Kiniksa Pharmaceuticals Corp. | 1 | $109,802 |
| Sun Pharmaceutical Industries, Inc. | 1 | $136,809 |
| Valo Health, Inc. | 1 | $115,000 |
| Genezen MA, Inc. | 1 | $100,776 |
| Braskem America, Inc. | 1 | $161,245 |
| Orum Therapeutics USA, Inc. | 1 | $160,217 |
Tit travay
- Scientist II, Process Development4
- Senior Scientist3
- Senior Scientist I, Process Development3
- Scientist I, Process Development2
- Senior Scientist I2
- QC Scientist2
- Senior Research Associate2
- Engineer I/Scientist I1
- Quality Control Analyst1
- Sr. Specialist PD & Research1
- Scientist1
- Scientist, Analytical Science & Quality Testing1
- Senior Scientist I, Analytical Development1
- Senior Scientist, Analytical Chemistry1
- Scientist I, Medicinal Chemistry1
Pwonse H-1B nan Lexington, MA →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).